30 min listen
Coronavirus (COVID-19) Update: Early Safety Signals Around Ibuprofen and Renin-Angiotensin Inhibitors
Coronavirus (COVID-19) Update: Early Safety Signals Around Ibuprofen and Renin-Angiotensin Inhibitors
ratings:
Length:
9 minutes
Released:
Mar 20, 2020
Format:
Podcast episode
Description
Emerging information about how SARS-CoV-2 virus infects cells has led to speculation that NSAIDs and ACE inhibitors/angiotensin receptor blockers (ARBs) may worsen clinical disease. Infectious disease physician Carlos del Rio, MD, of Emory University explains the concerns and their clinical implications.
Released:
Mar 20, 2020
Format:
Podcast episode
Titles in the series (100)
Mendelian Randomization: How the Natural Assortment of Genes Can Mimic Randomized Clinical Trials: The best evidence for proving cause-and-effect comes from randomized clinical trials. However, they are expensive and difficult to perform. The natural assortment of gene variants at birth can mimic randomization in some circumstances and yield... by JAMA Clinical Reviews